Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$437K Buy
1,806
+16
+0.9% +$3.93K 0.34% 69
2022
Q4
$470K Sell
1,790
-106
-6% -$28.4K 0.39% 68
2022
Q3
$427K Buy
1,896
+60
+3% +$14.5K 0.26% 83
2022
Q2
$447K Buy
1,836
+9
+0.5% +$2.21K 0.29% 85
2022
Q1
$442K Sell
1,827
-780
-30% -$179K 0.22% 105
2021
Q4
$587K Buy
2,607
+10
+0.4% +$2.11K 0.29% 88
2021
Q3
$552K Buy
2,597
+8
+0.3% +$1.84K 0.28% 91
2021
Q2
$631K Buy
2,589
+375
+17% +$92.3K 0.36% 68
2021
Q1
$551 Sell
2,214
-610
-22% -$146K 0.24% 81
2020
Q4
$693K Buy
2,824
+1,651
+141% +$381K 0.39% 67
2020
Q3
$298K Sell
1,173
-150
-11% -$37.2K 0.18% 108
2020
Q2
$312K Sell
1,323
-1,931
-59% -$441K 0.2% 88
2020
Q1
$660K Buy
3,254
+558
+21% +$122K 0.59% 41
2019
Q4
$650K Buy
+2,696
New +$594K 0.46% 58

Other funds holding AMGN

Asset Management Corp's AMGN Position: Q1 2023 in Review

Asset Management Corp increased its Amgen (AMGN) stake by 0.89% in Q1 2023, buying an estimated $3.93K and bringing the position to 1,806 shares worth $437K. The position accounts for 0.34% of the portfolio, ranked #69.

Asset Management Corp first reported a position in AMGN in Q4 2019 and has held it in 14 quarters since. The position peaked at $693K in Q4 2020. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Asset Management Corp held 1,806 shares of Amgen worth $437K as of Q1 2023.
  • Asset Management Corp bought 16 Amgen shares in Q1 2023, an estimated $3.93K.
  • Amgen made up 0.34% of Asset Management Corp's portfolio in Q1 2023, its #69 holding.
  • Asset Management Corp first reported a position in Amgen in Q4 2019 and has held it in 14 quarters since.
  • Asset Management Corp's Amgen position peaked at $693K in Q4 2020.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.